State Street’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,582
| Closed | -$382K | – | 4283 |
|
|
2024
Q4 | $382K | Buy |
+9,582
| New | +$382K | ﹤0.01% | 3691 |
|
|
2024
Q3 | – | Sell |
-4,285
| Closed | -$37.5K | – | 4297 |
|
|
2024
Q2 | $37.5K | Buy |
4,285
+388
| +10% | +$3.4K | ﹤0.01% | 4194 |
|
|
2024
Q1 | $95.5K | Hold |
3,897
| – | – | ﹤0.01% | 4037 |
|
|
2023
Q4 | $64.7K | Hold |
3,897
| – | – | ﹤0.01% | 4147 |
|
|
2023
Q3 | $72.8K | Hold |
3,897
| – | – | ﹤0.01% | 4192 |
|
|
2023
Q2 | $94.6K | Hold |
3,897
| – | – | ﹤0.01% | 4255 |
|
|
2023
Q1 | $85.1K | Buy |
3,897
+1,464
| +60% | +$32K | ﹤0.01% | 4371 |
|
|
2022
Q4 | $58K | Hold |
2,433
| – | – | ﹤0.01% | 4526 |
|
|
2022
Q3 | $67K | Hold |
2,433
| – | – | ﹤0.01% | 4586 |
|
|
2022
Q2 | $74K | Sell |
2,433
-13,757
| -85% | -$418K | ﹤0.01% | 4626 |
|
|
2022
Q1 | $870K | Buy |
16,190
+589
| +4% | +$31.7K | ﹤0.01% | 3852 |
|
|
2021
Q4 | $4.63M | Buy |
15,601
+632
| +4% | +$188K | ﹤0.01% | 3277 |
|
|
2021
Q3 | $5.8M | Buy |
14,969
+3,026
| +25% | +$1.17M | ﹤0.01% | 3151 |
|
|
2021
Q2 | $6.09M | Buy |
11,943
+5,057
| +73% | +$2.58M | ﹤0.01% | 3146 |
|
|
2021
Q1 | $3.91M | Buy |
6,886
+489
| +8% | +$278K | ﹤0.01% | 3157 |
|
|
2020
Q4 | $4.42M | Buy |
+6,397
| New | +$4.42M | ﹤0.01% | 3020 |
|